Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 13, Number 3—March 2007

Research

In Vitro Cell Culture Infectivity Assay for Human Noroviruses

Timothy M. Straub*Comments to Author , Kerstin Höner zu Bentrup†, Patricia Orosz Coghlan‡, Alice Dohnalkova*, Brooke K. Mayer*1, Rachel A. Bartholomew*, Catherine O. Valdez*, Cynthia J. Bruckner-Lea*, Charles P. Gerba‡, Morteza A. Abbaszadegan§, and Cheryl A. Nickerson†1
Author affiliations: *Pacific Northwest National Laboratory, Richland, Washington, USA; †Tulane University School of Medicine, New Orleans, Louisiana, USA; ‡University of Arizona, Tucson, Arizona, USA; §Arizona State University, Tempe, Arizona, USA;

Main Article

Figure 5

Deconvolved confocal laser scanning micrographs of the molecular beacon fluorescence in situ hybridization assay, demonstrating viral infectivity of a genogroup I virus (Sample 155) and genogroup II virus (flag2). A) Typical response for uninfected cells, no molecular beacon observed. B) Sample 155, P5 in cell culture. C) Sample flag2, P5 in cell culture.

Figure 5. Deconvolved confocal laser scanning micrographs of the molecular beacon fluorescence in situ hybridization assay, demonstrating viral infectivity of a genogroup I virus (Sample 155) and genogroup II virus (flag2). A) Typical response for uninfected cells, no molecular beacon observed. B) Sample 155, P5 in cell culture. C) Sample flag2, P5 in cell culture.

Main Article

1Current affiliation: Arizona State University, Tempe, Arizona, USA

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO